131 related articles for article (PubMed ID: 37552107)
1. Peritumoral Radiomics for Identification of Telomerase Reverse Transcriptase Promoter Mutation in Patients With Glioblastoma Based on Preoperative MRI.
Zhang H; Zhou B; Zhang H; Zhang Y; Lei Y; Huang B
Can Assoc Radiol J; 2024 Feb; 75(1):143-152. PubMed ID: 37552107
[No Abstract] [Full Text] [Related]
2. Deep Learning Radiomics for the Assessment of Telomerase Reverse Transcriptase Promoter Mutation Status in Patients With Glioblastoma Using Multiparametric MRI.
Zhang H; Zhang H; Zhang Y; Zhou B; Wu L; Lei Y; Huang B
J Magn Reson Imaging; 2023 Nov; 58(5):1441-1451. PubMed ID: 36896953
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric MRI-based fusion radiomics for predicting telomerase reverse transcriptase (TERT) promoter mutations and progression-free survival in glioblastoma: a multicentre study.
Zhang H; Zhang H; Zhang Y; Zhou B; Wu L; Yang W; Lei Y; Huang B
Neuroradiology; 2024 Jan; 66(1):81-92. PubMed ID: 37978079
[TBL] [Abstract][Full Text] [Related]
4. A radiomics-based nomogram may be useful for predicting telomerase reverse transcriptase promoter mutation status in adult glioblastoma.
Li Y; Chen L; Huang L; Li X; Huang Q; Tang L; Huang Z; Zhu L; Li T
Brain Behav; 2024 May; 14(5):e3528. PubMed ID: 38798094
[TBL] [Abstract][Full Text] [Related]
5. Glioblastoma and Solitary Brain Metastasis: Differentiation by Integrating Demographic-MRI and Deep-Learning Radiomics Signatures.
Zhang Y; Zhang H; Zhang H; Ouyang Y; Su R; Yang W; Huang B
J Magn Reson Imaging; 2023 Nov; ():. PubMed ID: 37955154
[TBL] [Abstract][Full Text] [Related]
6. Sub-region based radiomics analysis for prediction of isocitrate dehydrogenase and telomerase reverse transcriptase promoter mutations in diffuse gliomas.
Zhang H; Ouyang Y; Zhang H; Zhang Y; Su R; Zhou B; Yang W; Lei Y; Huang B
Clin Radiol; 2024 May; 79(5):e682-e691. PubMed ID: 38402087
[TBL] [Abstract][Full Text] [Related]
7. Multi-parameter MRI based radiomics nomogram for predicting telomerase reverse transcriptase promoter mutation and prognosis in glioblastoma.
Chen L; Chen R; Li T; Tang C; Li Y; Zeng Z
Front Neurol; 2023; 14():1266658. PubMed ID: 37830090
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral and Peritumoral Multiparametric MRI-Based Radiomics Signature for Preoperative Prediction of Ki-67 Proliferation Status in Glioblastoma: A Two-Center Study.
Zhu X; He Y; Wang M; Shu Y; Lai X; Gan C; Liu L
Acad Radiol; 2024 Apr; 31(4):1560-1571. PubMed ID: 37865602
[TBL] [Abstract][Full Text] [Related]
9. A radiomics feature-based nomogram to predict telomerase reverse transcriptase promoter mutation status and the prognosis of lower-grade gliomas.
Lu J; Li X; Li H
Clin Radiol; 2022 Aug; 77(8):e560-e567. PubMed ID: 35595562
[TBL] [Abstract][Full Text] [Related]
10. Conventional magnetic resonance imaging-based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas.
Jiang C; Kong Z; Zhang Y; Liu S; Liu Z; Chen W; Liu P; Liu D; Wang Y; Lyu Y; Zhao D; Wang Y; You H; Feng F; Ma W
Neuroradiology; 2020 Jul; 62(7):803-813. PubMed ID: 32239241
[TBL] [Abstract][Full Text] [Related]
11. MRI radiomics model for predicting TERT promoter mutation status in glioblastoma.
Chen L; Chen R; Li T; Huang L; Tang C; Li Y; Zeng Z
Brain Behav; 2023 Dec; 13(12):e3324. PubMed ID: 38054695
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral and Peritumoral Analysis of Mammography, Tomosynthesis, and Multiparametric MRI for Predicting Ki-67 Level in Breast Cancer: a Radiomics-Based Study.
Jiang T; Song J; Wang X; Niu S; Zhao N; Dong Y; Wang X; Luo Y; Jiang X
Mol Imaging Biol; 2022 Aug; 24(4):550-559. PubMed ID: 34904187
[TBL] [Abstract][Full Text] [Related]
13. Multi-parametric MRI-based peritumoral radiomics on prediction of lymph-vascular space invasion in early-stage cervical cancer.
Cui L; Yu T; Kan Y; Dong Y; Luo Y; Jiang X
Diagn Interv Radiol; 2022 Jul; 28(4):312-321. PubMed ID: 35731710
[TBL] [Abstract][Full Text] [Related]
14. MRI-based multiregional radiomics for preoperative prediction of tumor deposit and prognosis in resectable rectal cancer: a bicenter study.
Li H; Chen XL; Liu H; Liu YS; Li ZL; Pang MH; Pu H
Eur Radiol; 2023 Nov; 33(11):7561-7572. PubMed ID: 37160427
[TBL] [Abstract][Full Text] [Related]
15. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS
Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric Magnetic Resonance Imaging-Based Peritumoral Radiomics for Preoperative Prediction of the Presence of Extracapsular Extension With Prostate Cancer.
Bai H; Xia W; Ji X; He D; Zhao X; Bao J; Zhou J; Wei X; Huang Y; Li Q; Gao X
J Magn Reson Imaging; 2021 Oct; 54(4):1222-1230. PubMed ID: 33970517
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral and peritumoral radiomics for preoperative prediction of neoadjuvant chemotherapy effect in breast cancer based on contrast-enhanced spectral mammography.
Mao N; Shi Y; Lian C; Wang Z; Zhang K; Xie H; Zhang H; Chen Q; Cheng G; Xu C; Dai Y
Eur Radiol; 2022 May; 32(5):3207-3219. PubMed ID: 35066632
[TBL] [Abstract][Full Text] [Related]
18. Radiomics Analysis Based on Magnetic Resonance Imaging for Preoperative Overall Survival Prediction in Isocitrate Dehydrogenase Wild-Type Glioblastoma.
Wang S; Xiao F; Sun W; Yang C; Ma C; Huang Y; Xu D; Li L; Chen J; Li H; Xu H
Front Neurosci; 2021; 15():791776. PubMed ID: 35153659
[TBL] [Abstract][Full Text] [Related]
19. MRI-based peritumoral radiomics analysis for preoperative prediction of lymph node metastasis in early-stage cervical cancer: A multi-center study.
Shi J; Dong Y; Jiang W; Qin F; Wang X; Cui L; Liu Y; Jin Y; Luo Y; Jiang X
Magn Reson Imaging; 2022 May; 88():1-8. PubMed ID: 34968703
[TBL] [Abstract][Full Text] [Related]
20. Intra- and Peritumoral Based Radiomics for Assessment of Lymphovascular Invasion in Invasive Breast Cancer.
Jiang W; Meng R; Cheng Y; Wang H; Han T; Qu N; Yu T; Hou Y; Xu S
J Magn Reson Imaging; 2024 Feb; 59(2):613-625. PubMed ID: 37199241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
